Mouse models of cognitive disorders in trisomy 21:: A review

被引:48
|
作者
Seregaza, Zohra
Roubertoux, Pierre L.
Jamon, Marc
Soumireu-Mourat, Bernard
机构
[1] Univ Mediterranee, UMR 6196, P3M, CNRS, F-13402 Marseille 20, France
[2] Univ Aix Marseille 1, Ctr St Charles, CNRS, UMR 6149, Marseille, France
关键词
cognition; Down's syndrome; learning disorders; memory; mental retardation; transgenic mice; trisomy; 21;
D O I
10.1007/s10519-006-9056-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Trisomy 21 (TRS21) is the most frequent genetic cause of mental retardation. Although the presence of an extra copy of HSA21 is known to be at the origin of the syndrome, we do not know which 225 HSA21 genes have an effect on cognitive processes. Mouse models of TRS21 have been developed using syntenies between HSA21 and MMU16, MMU10 and MMU17. Available mouse models carry extra fragments of MMU16 or of HSA21 that cover all of HSA21 (chimeric HSA21) or MMU16 (Ts16); some carry large parts of MMU16 (Ts65Dn, Ts1Cje, Ms1Cje), while others have reduced contiguous fragments covering the D21S17-ETS2 region or single transfected genes. This offers a nest design strategy for deciphering cognitive (learning, memory and exploration) and associated brain abnormalities involving each of these chromosomal regions. This review confirms the crucial but not exclusive contribution of the D21S17-ETS2 region encompassing 16 genes to cognitive disorders.
引用
收藏
页码:387 / 404
页数:18
相关论文
共 50 条
  • [31] MOUSE MODELS OF JOINT DISORDERS
    Hilton, M. J.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 : S6 - S6
  • [32] Mouse models for psychiatric disorders
    Seong, E
    Seasholtz, AF
    Burmeister, M
    TRENDS IN GENETICS, 2002, 18 (12) : 643 - 650
  • [33] Trisomy 21
    Pereira, Elaine Maria
    PEDIATRICS IN REVIEW, 2024, 45 (02) : 116 - 117
  • [34] MOUSE TRISOMY-16 - AN ANIMAL-MODEL OF HUMAN TRISOMY-21 (DOWN SYNDROME)
    EPSTEIN, CJ
    COX, DR
    EPSTEIN, LB
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 450 (JUN) : 157 - 168
  • [35] GATA1 analysis in myeloproliferative disorders associated to trisomy 21
    Fuster Soler, J. L.
    Norton, A.
    Galera Minarro, A.
    Bermudez Cortes, M.
    Llinares Riestra, M. E.
    Ortuno Giner, F.
    ANALES DE PEDIATRIA, 2011, 74 (01): : 31 - 37
  • [36] Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development
    Adams, April D.
    Guedj, Faycal
    Bianchi, Diana W.
    PLACENTA, 2020, 89 : 58 - 66
  • [37] PRENATAL SONOGRAPHIC FINDINGS IN TRISOMY-13, TRISOMY-18, TRISOMY-21 AND TRISOMY-22 - A REVIEW OF 46 CASES
    SEOUD, MAF
    ALLEY, DC
    SMITH, DL
    LEVY, DL
    JOURNAL OF REPRODUCTIVE MEDICINE, 1994, 39 (10) : 781 - 787
  • [38] EPIDEMIOLOGY OF TRISOMY-21 - A REVIEW AND THEORETICAL-ANALYSIS
    JANERICH, DT
    BRACKEN, MB
    JOURNAL OF CHRONIC DISEASES, 1986, 39 (12): : 1079 - 1093
  • [39] Suicidal behavior among individuals with trisomy 21: an integrative review
    de Oliveira, Daniel Galvao
    Prado, Juliana de Almeida
    Melo, Debora Gusmao
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2024, 36 (4-5) : 424 - 433
  • [40] Challenges in Patients with Trisomy 21: A Review of Current Knowledge and Recommendations
    Robinson, Jennifer
    Pompe, Manca Tekavcic
    Gerth-Kahlert, Christina
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021